DNA Polymerase (cid:100) Is Required for Human Mismatch Repair in Vitro *
暂无分享,去创建一个
[1] L. Rogge,et al. Purification of mammalian DNA polymerases: DNA polymerase α , 1995 .
[2] B. Vogelstein,et al. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. , 1995, Oncogene.
[3] P. Modrich,et al. Strand-specific mismatch correction in nuclear extracts of human and Drosophila melanogaster cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Meuth,et al. Mutator phenotypes in human colorectal carcinoma cell lines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] E. Davie,et al. Primary structure of the catalytic subunit of calf thymus DNA polymerase delta: sequence similarities with other DNA polymerases. , 1991, Biochemistry.
[6] J. Griffith,et al. Bidirectional excision in methyl-directed mismatch repair. , 1993, The Journal of biological chemistry.
[7] P. Modrich,et al. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. , 1996, Annual review of biochemistry.
[8] W. Copeland,et al. Initiation of simian virus 40 DNA replication requires the interaction of a specific domain of human DNA polymerase alpha with large T antigen , 1993, Molecular and cellular biology.
[9] M. Radman. Mismatch repair and the fidelity of genetic recombination. , 1989, Genome.
[10] W. Fang,et al. Human strand-specific mismatch repair occurs by a bidirectional mechanism similar to that of the bacterial reaction. , 1993, The Journal of biological chemistry.
[11] N. Copeland,et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer , 1993, Cell.
[12] B. Stillman,et al. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein , 1987, Nature.
[13] Bert Vogelstein,et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells , 1993, Cell.
[14] M. Hawn,et al. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. , 1995, Cancer research.
[15] K. Kinzler,et al. Mutations of GTBP in genetically unstable cells. , 1995, Science.
[16] M. Radman,et al. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer , 1995, Cell.
[17] D. Ward,et al. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.
[18] C. Boland,et al. Loss of DNA mismatch repair in acquired resistance to cisplatin. , 1996, Cancer research.
[19] P. Modrich,et al. Methyl-directed mismatch repair is bidirectional. , 1993, The Journal of biological chemistry.
[20] Asad Umar,et al. Requirement for PCNA in DNA Mismatch Repair at a Step Preceding DNA Resynthesis , 1996, Cell.
[21] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[22] G. Aquilina,et al. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage , 1993, Nature.
[23] J. Jiricny,et al. hMutSβ, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA , 1996, Current Biology.
[24] G. Hannon,et al. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.
[25] D. Lilley,et al. Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] G. Marsischky,et al. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Fleischmann,et al. Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.
[28] P. Modrich,et al. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. , 1995, Science.
[29] R. Fleischmann,et al. Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.
[30] Robin J. Leach,et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.
[31] R. Kolodner,et al. Biochemistry and genetics of eukaryotic mismatch repair. , 1996, Genes & development.
[32] B. Stillman,et al. Identification of replication factor C from Saccharomyces cerevisiae: a component of the leading-strand DNA replication complex , 1992, Molecular and cellular biology.
[33] N. Brown,et al. Mechanisms of inhibition of DNA polymerases by 2'-deoxyribonucleoside 5'-triphosphate analogs. , 1995, Methods in enzymology.
[34] Tomas A. Prolla,et al. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair , 1993, Nature.
[35] J. Essigmann,et al. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. , 1996, Chemistry & biology.
[36] D. Shibata,et al. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation , 1994, Nature Genetics.
[37] Peter Beighton,et al. de la Chapelle, A. , 1997 .
[38] C. Tan,et al. An auxiliary protein for DNA polymerase-delta from fetal calf thymus. , 1986, The Journal of biological chemistry.
[39] P. Modrich,et al. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Brown,et al. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. , 1996, Cancer research.
[41] A. Chapelle,et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability , 1995, Nature Genetics.
[42] V. Pirrotta,et al. General purification schemes for restriction endonucleases. , 1980, Methods in enzymology.
[43] W. Thilly,et al. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[44] P. Modrich,et al. Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line* , 1996, The Journal of Biological Chemistry.
[45] A. Kwong,et al. Synthesis of DNA by DNA polymerase ε in vitro , 1991 .
[46] R. Bravo,et al. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ , 1987, Nature.
[47] J. Jiricny,et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. , 1995, Science.
[48] R. Berg,et al. Measurement of Nitrate and Nitrite in Extracellular Fluids: A Window to Systemic Nitric Oxide Metabolism , 1995 .